Check out our wide range of fillers and injectables.
Revofil is a range of injectable dermal fillers developed and commercialized by the South Korean company Caregen. The Revofil portfolio comprises 2 sets of dermal fillers: Fine, Plus and Ultra, which are made of cross-linked hyaluronic acid, and Revofil Aquashine and AquashineBR, which are made of non-crosslinked hyaluronic acid.
The Revofil range treats wrinkles, minor hyperpigmentation, and is able to sculpt and shape the skin tissue to by adding volume and smoothing out the skin. With an innovative formulation that promotes stability of the product within the skin, patients will enjoy longer lasting effects compared to other dermal fillers available.
Patients who are above the age of 21 and are seeking to correct skin-related signs of aging such as wrinkles, deep folds, sagging or sunken facial areas, and hyperpigmentation such as age spots are good candidates. As well, those seeking to sculpt certain areas of the face, such as the lips, cheekbones, jawline, and/or to rejuvenate their skin overall are well-suited for Revofil treatments.
Revofil cosmetic fillers are not recommended for pregnant or breastfeeding women, individuals under 18 years old, or individuals who are hypersensitive or allergic to hyaluronic acid or its derivatives.
With hyaluronic acid as its principal component, Revofil products treat aging-related skin concerns such as wrinkles and folds through two modes of action. Firstly, Revofil adds volume to the area being treated when injected into the skin, resulting in a lifting and plumping of the skin. This acts to smooth out folds and lines in the skin. Also, this treatment induces collagen production which helps to restore elasticity and volume.
Revofil Fine, Plus and Ultra fillers incorporate peptides that serve as stabilizers and hyaluronidase inhibitors into their formulation. As a result, treatment with Revofil dermal fillers provides longer lasting effects when compared with other hyaluronic acid cosmetic injectables. Revofil Aquashine products contain a complex of bioactive ingredients in addition to hyaluronic acid such as vitamins and amino acids, all of which help to revitalize and rejuvenate tired and dull skin.
These aesthetic injectables are safe to use, and they have higher efficiency than other products which makes them unique and popular.
Revofil fillers should only be administered by a licensed medical practitioner with specific training. The procedure is very simple, consisting of an injection to the skin in the area to be treated. Sometimes, a local anesthetic is administered prior to injection for the patient’s comfort. The entire procedure takes about 30-90 minutes, depending on the area treated and quantity of filler used. In order to maintain results, touch up treatments should be performed at least once within 10–12 months of initial treatment.
For Revofil Aquashine products, the recommended course of treatment for fine line, wrinkles, and pigmentation issues is 3 sessions every 4 weeks, with 2-3 session in a year for the maintenance of effects.
Revofil fillers have been clinically proven to last longer than their competitors, due to the stabilizing qualities of their formulation. The duration of effect depends on a few factors such as the quantity injected, as well as the patient’s metabolism; however, treatment consisting of a single injection will typically last for at least 10 months to 1 year.
Revofil dermal fillers have been extensively researched and clinically tested with proven safety results. The products are certified by regulatory agents.
There have been very little adverse effects reported with the use of Revofil injectables; however, patients should expect some swelling, redness or pain at the site of injection.
Your patients will enjoy instant results and can resume their daily activities immediately after treatment. Advise them on any aftercare methods to ease injection-related symptoms.
On average, the cost of a single dermal filler treatment in the US is $500 to $800; however, patients can expect Revofil to be a more affordable option when compared with its competitors.